The National Institutes of Health established the Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium in 2021 with the goal of finding molecular diagnoses for individuals with rare diseases who remain undiagnosed after clinical testing – to solve the unsolved. Baylor College of Medicine is one of five clinical sites in the consortium.
This article was originally published on MedicalXpress.com

